|
1
|
Kutok JL and Wang F: Spectrum of Epstein
Barr virus associated diseases. Annu Rev Pathol. 1:375–404. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Williams H and Crawford DH: Epstein-Barr
virus: The impact of scientific advances on clinical practice.
Blood. 107:862–869. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lo KW, To KF and Huang DP: Focus on
nasopharyngeal carcinoma. Cancer Cell. 5:423–428. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cesarman E: Gammaherpesvirus and
lymphoproliferative disorders in immunocompromised patients. Cancer
Lett. 305:163–174. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hsieh JJ and Hayward SD: Masking of the
CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr
virus EBNA2. Science. 268:560–563. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yoshizaki T, Kondo S, Wakisaka N, Murono
S, Endo K, Sugimoto H, Nakanishi S, Tsuji A and Ito M: Pathogenic
role of Epstein-Barr virus latent membrane protein-1 in the
development of nasopharyngeal carcinoma. Cancer Lett. 337:1–7.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guasparri I, Bubman D and Cesarman E: EBV
LMP2A affects LMP1-mediated NF-kappaB signaling and survival of
lymphoma cells by regulating TRAF2 expression. Blood.
111:3813–3820. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Marquitz AR, Mathur A, Edwards RH and
Raab-Traub N: Host gene expression is regulated by two types of
noncoding RNAs transcribed from the Epstein-Barr virus BamHI A
rightward transcript region. J Virol. 89:11256–11268. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Winter J, Jung S, Keller S, Gregory RI and
Diederichs S: Many roads to maturity: microRNA biogenesis pathways
and their regulation. Nat Cell Biol. 11:228–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Han J, Lee Y, Yeom KH, Nam JW, Heo I, Rhee
JK, Sohn SY, Cho Y, Zhang BT and Kim VN: Molecular basis for the
recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell.
125:887–901. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Busson P, Keryer C, Ooka T and Corbex M:
EBV-associated nasopharyngeal carcinomas: From epidemiology to
virus-targeting strategies. Trends Microbiol. 12:356–360. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pfeffer S, Zavolan M, Grässer FA, Chien M,
Russo JJ, Ju J, John B, Enright AJ, Marks D, Sander C and Tuschl T:
Identification of virus-encoded microRNAs. Science. 304:734–736.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu JY, Pfuhl T, Motsch N, Barth S,
Nicholls J, Grässer F and Meister G: Identification of novel
Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas. J
Virol. 83:3333–3341. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Edwards RH, Marquitz AR and Raab-Traub N:
Epstein-Barr virus BART microRNAs are produced from a large intron
prior to splicing. J Virol. 82:9094–9106. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qiu J, Cosmopoulos K, Pegtel M, Hopmans E,
Murray P, Middeldorp J, Shapiro M and Thorley-Lawson DA: A novel
persistence associated EBV miRNA expression profile is disrupted in
neoplasia. PLoS Pathog. 7:e10021932011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tsai CY, Liu YY, Liu KH, Hsu JT, Chen TC,
Chiu CT and Yeh TS: Comprehensive profiling of virus microRNAs of
Epstein-Barr virus-associated gastric carcinoma: Highlighting the
interactions of ebv-Bart9 and host tumor cells. J Gastroenterol
Hepatol. 32:82–91. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sakamoto K, Sekizuka T, Uehara T, Hishima
T, Mine S, Fukumoto H, Sato Y, Hasegawa H, Kuroda M and Katano H:
Next-generation sequencing of miRNAs in clinical samples of
Epstein-Barr virus-associated B-cell lymphomas. Cancer Med.
6:605–618. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lo AKF, Dawson CW, Jin DY and Lo KW: The
pathological roles of BART miRNAs in nasopharyngeal carcinoma. J
Pathol. 227:392–403. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Baer R, Bankier AT, Biggin MD, Deininger
PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC,
Séguin C, et al: DNA sequence and expression of the B95-8
Epstein-Barr virus genome. Nature. 310:207–211. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pratt ZL, Kuzembayeva M, Sengupta S and
Sugden B: The microRNAs of Epstein-Barr Virus are expressed at
dramatically differing levels among cell lines. Virology.
386:387–397. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xia T, O'Hara A, Araujo I, Barreto J,
Carvalho E, Sapucaia JB, Ramos JC, Luz E, Pedroso C, Manrique M, et
al: EBV microRNAs in primary lymphomas and targeting of CXCL-11 by
ebv-mir-BHRF1-3. Cancer Res. 68:1436–1442. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim DN, Chae HS, Oh ST, Kang JH, Park CH,
Park WS, Takada K, Lee JM, Lee WK and Lee SK: Expression of viral
microRNAs in Epstein-Barr virus-associated gastric carcinoma. J
Virol. 81:1033–1036. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cosmopoulos K, Pegtel M, Hawkins J,
Moffett H, Novina C, Middeldorp J and Thorley-Lawson DA:
Comprehensive profiling of Epstein-Barr virus microRNAs in
nasopharyngeal carcinoma. J Virol. 83:2357–2367. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen SJ, Chen GH, Chen YH, Liu CY, Chang
KP, Chang YS and Chen HC: Characterization of Epstein-Barr virus
miRNAome in nasopharyngeal carcinoma by deep sequencing. PLoS One.
5(pii): e127452010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Motsch N, Alles J, Imig J, Zhu J, Barth S,
Reineke T, Tinguely M, Cogliatti S, Dueck A, Meister G, et al:
MicroRNA profiling of Epstein-Barr virus-associated NK/T-cell
lymphomas by deep sequencing. PLoS One. 7:e421932012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jun SM, Hong YS, Seo JS, Ko YH, Yang CW
and Lee SK: Viral microRNA profile in Epstein-Barr virus-associated
peripheral T cell lymphoma. Brit J Haematol. 142:320–323. 2008.
View Article : Google Scholar
|
|
28
|
Arikawa J, Tokunaga M, Tashiro Y, Tanaka
S, Sato E, Haraguchi K, Yamamoto A, Toyohira O and Tsuchimochi A:
Epstein-Barr virus-positive multiple early gastric cancers and
dysplastic lesions: A case report. Pathol Int. 47:730–734. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fukayama M: Epstein-Barr virus and gastric
carcinoma. Pathol Int. 60:337–350. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wong AM, Kong KL, Tsang JW, Kwong DL and
Guan XY: Profiling of Epstein-Barr virus-encoded microRNAs in
nasopharyngeal carcinoma reveals potential biomarkers and oncomirs.
Cancer. 118:698–710. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee
DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al:
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic
Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Amoroso R, Fitzsimmons L, Thomas WA, Kelly
GL, Rowe M and Bell AI: Quantitative studies of Epstein-Barr
virus-encoded microRNAs provide novel insights into their
regulation. J Virol. 85:996–1010. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chan JY, Gao W, Ho WK, Wei WI and Wong TS:
Overexpression of Epstein-Barr virus-encoded microRNA-BART7 in
undifferentiated nasopharyngeal carcinoma. Anticancer Res.
32:3201–3210. 2012.PubMed/NCBI
|
|
34
|
Cai X, Schäfer A, Lu S, Bilello JP,
Desrosiers RC, Edwards R, Raab-Traub N and Cullen BR: Epstein-Barr
virus microRNAs are evolutionarily conserved and differentially
expressed. PLoS Pathog. 2:e232006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Neuhierl B and Delecluse HJ: Molecular
genetics of DNA viruses: Recombinant virus technology. Methods Mol
Biol. 292:353–370. 2005.PubMed/NCBI
|
|
36
|
Feederle R, Linnstaedt SD, Bannert H, Lips
H, Bencun M, Cullen BR and Delecluse HJ: A viral microRNA cluster
strongly potentiates the transforming properties of a human
herpesvirus. PLoS Pathog. 7:e10012942011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tsao SW, Tsang CM and Lo KW: Epstein-Barr
virus infection and nasopharyngeal carcinoma. Philos Trans R Soc
Lond B Biol Sci. 372(pii): 201602702017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Young LS and Dawson CW: Epstein-Barr virus
and nasopharyngeal carcinoma. Chin J Cancer. 33:581–590.
2014.PubMed/NCBI
|
|
39
|
Zheng X, Wang J, Wei L, Peng Q, Gao Y, Fu
Y, Lu Y, Qin Z, Zhang X, Lu J, et al: Epstein-Barr virus MicroRNA
miR-BART5-3p inhibits p53 expression. J Virol. 92(pii): e01022–18.
2018.PubMed/NCBI
|
|
40
|
Marquitz AR, Mathur A, Nam CS and
Raab-Traub N: The Epstein-Barr virus BART microRNAs target the
pro-apoptotic protein Bim. Virology. 412:392–400. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Choy EY, Siu KL, Kok KH, Lung RW, Tsang
CM, To KF, Kwong DL, Tsao SW and Jin DY: An Epstein-Barr
virus-encoded microRNA targets PUMA to promote host cell survival.
J Exp Med. 205:2551–2560. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lei T, Yuen KS, Xu R, Tsao SW, Chen H, Li
M, Kok KH and Jin DY: Targeting of DICE1 tumor suppressor by
Epstein-Barr virus-encoded miR-BART3* microRNA in nasopharyngeal
carcinoma. Int J Cancer. 133:79–87. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cai L, Ye Y, Jiang Q, Chen Y, Lyu X, Li J,
Wang S, Liu T, Cai H, Yao K, et al: Epstein-Barr virus-encoded
microRNA BART1 induces tumour metastasis by regulating
PTEN-dependent pathways in nasopharyngeal carcinoma. Nat Commun.
6:73532015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cai LM, Lyu XM, Luo WR, Cui XF, Ye YF,
Yuan CC, Peng QX, Wu DH, Liu TF, Wang E, et al: EBV-miR-BART7-3p
promotes the EMT and metastasis of nasopharyngeal carcinoma cells
by suppressing the tumor suppressor PTEN. Oncogene. 34:2156–2166.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hsu CY, Yi YH, Chang KP, Chang YS, Chen SJ
and Chen HC: The Epstein-Barr virus-encoded microRNA MiR-BART9
promotes tumor metastasis by targeting E-cadherin in nasopharyngeal
carcinoma. PLoS Pathog. 10:e10039742014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Dölken L, Malterer G, Erhard F, Kothe S,
Friedel CC, Suffert G, Marcinowski L, Motsch N, Barth S, Beitzinger
M, et al: Systematic analysis of viral and cellular microRNA
targets in cells latently infected with human gamma-herpesviruses
by RISC immunoprecipitation assay. Cell Host Microbe. 7:324–334.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Iizasa H, Wulff BE, Alla NR, Maragkakis M,
Megraw M, Hatzigeorgiou A, Iwakiri D, Takada K, Wiedmer A, Showe L,
et al: Editing of Epstein-Barr virus-encoded BART6 microRNAs
controls their dicer targeting and consequently affects viral
latency. J Biol Chem. 285:33358–33370. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Nachmani D, Stern-Ginossar N, Sarid R and
Mandelboim O: Diverse herpesvirus microRNAs target the
stress-induced immune ligand MICB to escape recognition by natural
killer cells. Cell Host Microbe. 5:376–385. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lo AK, To KF, Lo KW, Lung RW, Hui JW, Liao
G and Hayward SD: Modulation of LMP1 protein expression by
EBV-encoded microRNAs. Proc Natl Acad Sci USA. 104:16164–16169.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Lung RW, Tong JH, Sung YM, Leung PS, Ng
DC, Chau SL, Chan AW, Ng EK, Lo KW and To KF: Modulation of LMP2A
expression by a newly identified Epstein-Barr virus-encoded
microRNA miR-BART22. Neoplasia. 11:1174–1184. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhang X, Dawson CW, He Z and Huang P:
Immune evasion strategies of the human gamma-herpesviruses:
Implications for viral tumorigenesis. J Med Virol. 84:272–281.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Seto E, Moosmann A, Gromminger S, Walz N,
Grundhoff A and Hammerschmidt W: Micro RNAs of Epstein-Barr virus
promote cell cycle progression and prevent apoptosis of primary
human B cells. PLoS Pathog. 6:e10010632010. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Vereide DT, Seto E, Chiu YF, Hayes M,
Tagawa T, Grundhoff A, Hammerschmidt W and Sugden B: Epstein-Barr
virus maintains lymphomas via its miRNAs. Oncogene. 33:1258–1264.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ramalingam D, Kieffer-Kwon P and
Ziegelbauer JM: Emerging themes from EBV and KSHV microRNA targets.
Viruses. 4:1687–1710. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Fernandes Q, Merhi M, Raza A, Inchakalody
VP, Abdelouahab N, Zar Gul AR, Uddin S and Dermime S: Role of
Epstein-Barr virus in the pathogenesis of head and neck cancers and
its potential as an immunotherapeutic target. Front in Oncol.
8:2572018. View Article : Google Scholar
|
|
56
|
Albanese M, Tagawa T, Buschle A and
Hammerschmidt W: MicroRNAs of Epstein-Barr virus control innate and
adaptive antiviral immunity. J Virol. 91(pii): e01667–16.
2017.PubMed/NCBI
|
|
57
|
Poling BC, Price AM, Luftig MA and Cullen
BR: The Epstein-Barr virus miR-BHRF1 microRNAs regulate viral gene
expression in cis. Virology. 512:113–123. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Kim Y, Lee S, Kim S, Kim D, Ahn JH and Ahn
K: Human cytomegalovirus clinical strain-specific microRNA
miR-UL148D targets the human chemokine RANTES during infection.
PLoS Pathog. 8:e10025772012. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Haneklaus M, Gerlic M, Kurowska-Stolarska
M, Rainey AA, Pich D, McInnes IB, Hammerschmidt W, O'Neill LA and
Masters SL: Cutting edge: miR-223 and EBV miR-BART15 regulate the
NLRP3 inflammasome and IL-1β production. J Immunol. 189:3795–3799.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Kim S, Lee S, Shin J, Kim Y, Evnouchidou
I, Kim D, Kim YK, Kim YE, Ahn JH, Riddell SR, et al: Human
cytomegalovirus microRNA miR-US4-1 inhibits CD8(+) T cell responses
by targeting the aminopeptidase ERAP1. Nat Immunol. 12:984–991.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Bauman Y, Nachmani D, Vitenshtein A,
Tsukerman P, Drayman N, Stern-Ginossar N, Lankry D, Gruda R and
Mandelboim O: An identical miRNA of the human JC and BK polyoma
viruses targets the stress-induced ligand ULBP3 to escape immune
elimination. Cell Host Microbe. 9:93–102. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Abend JR, Ramalingam D, Kieffer-Kwon P,
Uldrick TS, Yarchoan R and Ziegelbauer JM: Kaposi's
sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88,
two components of the toll-like receptor/interleukin-1R signaling
cascade, to reduce inflammatory-cytokine expression. J Virol.
86:11663–11674. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Lei X, Bai Z, Ye F, Xie J, Kim CG, Huang Y
and Gao SJ: Regulation of NF-kappaB inhibitor IkappaBalpha and
viral replication by a KSHV microRNA. Nat Cell Biol. 12:193–199.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Liang D, Gao Y, Lin X, He Z, Zhao Q, Deng
Q and Lan K: A human herpesvirus miRNA attenuates interferon
signaling and contributes to maintenance of viral latency by
targeting IKKε. Cell Res. 21:793–806. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Hooykaas MJG, van Gent M, Soppe JA, Kruse
E, Boer IGJ, van Leenen D, Groot Koerkamp MJA, Holstege FCP,
Ressing ME, Wiertz EJHJ and Lebbink RJ: EBV MicroRNA BART16
suppresses type I IFN signaling. J Immunol. 198:4062–4073. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Skinner CM, Ivanov NS, Barr SA, Chen Y and
Skalsky RL: An Epstein-Barr virus microrna blocks interleukin-1
(IL-1) signaling by targeting IL-1 receptor 1. J Virol. 91(pii):
e00530–17. 2017.PubMed/NCBI
|
|
67
|
Dillon CP and Green DR: Molecular cell
biology of apoptosis and necroptosis in cancer. Adv Exp Med Biol.
930:1–23. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Kvansakul M, Caria S and Hinds MG: The
Bcl-2 family in host-virus interactions. Viruses. 9(pii): E2902017.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Kang D, Skalsky RL and Cullen BR: EBV BART
microRNAs target multiple pro-apoptotic cellular genes to promote
epithelial cell survival. PLoS Pathog. 11:e10049792015. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Kim H, Choi H and Lee SK: Epstein-Barr
virus miR-BART20-5p regulates cell proliferation and apoptosis by
targeting BAD. Cancer Lett. 356:733–742. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Kim H, Choi H and Lee SK: Epstein-Barr
virus MicroRNA miR-BART20-5p suppresses lytic induction by
inhibiting BAD-mediated caspase-3-dependent apoptosis. J Virol.
90:1359–1368. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Marquitz AR, Mathur A, Shair KH and
Raab-Traub N: Infection of Epstein-Barr virus in a gastric
carcinoma cell line induces anchorage independence and global
changes in gene expression. Proc Natl Acad Sci USA. 109:9593–9598.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Shinozaki-Ushiku A, Kunita A, Isogai M,
Hibiya T, Ushiku T, Takada K and Fukayama M: Profiling of
virus-encoded microRNAs in Epstein-Barr virus-associated gastric
carcinoma and their roles in gastric carcinogenesis. J Virol.
89:5581–5591. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Harold C, Cox D and Riley KJ: Epstein-Barr
viral microRNAs target caspase 3. Virol J. 13:1452016. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Choi H and Lee SK: TAX1BP1 downregulation
by EBV-miR-BART15-3p enhances chemosensitivity of gastric cancer
cells to 5-FU. Arch Virol. 162:369–377. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Ma J, Nie K, Redmond D, Liu Y, Elemento O,
Knowles DM and Tam W: EBV-miR-BHRF1-2 targets PRDM1/Blimp1:
Potential role in EBV lymphomagenesis. Leukemia. 30:594–604. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Bernhardt K, Haar J, Tsai MH, Poirey R,
Feederle R and Delecluse HJ: A viral microRNA cluster regulates the
expression of PTEN, p27 and of a bcl-2 homolog. PLoS Pathog.
12:e10054052016. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Engelman JA, Luo J and Cantley LC: The
evolution of phosphatidylinositol 3-kinases as regulators of growth
and metabolism. Nat Rev Genet. 7:606–619. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Zhang G, Zong J, Lin S, Verhoeven RJ, Tong
S, Chen Y, Ji M, Cheng W, Tsao SW, Lung M, et al: Circulating
Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers
for nasopharyngeal carcinoma diagnosis and treatment. Int J Cancer.
136:E301–E312. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Ferrajoli A, Ivan C, Ciccone M, Shimizu M,
Kita Y, Ohtsuka M, D'Abundo L, Qiang J, Lerner S, Nouraee N, et al:
Epstein-Barr virus microRNAs are expressed in patients with chronic
lymphocytic leukemia and correlate with overall survival.
EBioMedicine. 2:572–582. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Nordström M, Hardell L, Lindström G,
Wingfors H, Hardell K and Linde A: Concentrations of
organochlorines related to titers to Epstein-Barr virus early
antigen IgG as risk factors for hairy cell leukemia. Environ Health
Perspect. 108:441–445. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Sempere LF: Tissue slide-based microRNA
characterization of tumors: How detailed could diagnosis become for
cancer medicine? Expert Rev Mol Diagn. 14:853–869. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Mishra PJ: MicroRNAs as promising
biomarkers in cancer diagnostics. Biomark Res. 2:192014. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Ohshima K, Inoue K, Fujiwara A, Hatakeyama
K, Kanto K, Watanabe Y, Muramatsu K, Fukuda Y, Ogura S, Yamaguchi K
and Mochizuki T: Let-7 microRNA family is selectively secreted into
the extracellular environment via exosomes in a metastatic gastric
cancer cell line. PLoS One. 5:e132472010. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Zhao H, Shen J, Medico L, Wang D,
Ambrosone CB and Liu S: A pilot study of circulating miRNAs as
potential biomarkers of early stage breast cancer. PLoS One.
5:e137352010. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Pigati L, Yaddanapudi SC, Iyengar R, Kim
DJ, Hearn SA, Danforth D, Hastings ML and Duelli DM: Selective
release of microRNA species from normal and malignant mammary
epithelial cells. PLoS One. 5:e135152010. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Wei R, Huang GL, Zhang MY, Li BK, Zhang
HZ, Shi M, Chen XQ, Huang L, Zhou QM, Jia WH, et al: Clinical
significance and prognostic value of microRNA expression signatures
in hepatocellular carcinoma. Clin Cancer Res. 19:4780–4791. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Cheng H, Zhang L, Cogdell DE, Zheng H,
Schetter AJ, Nykter M, Harris CC, Chen K, Hamilton SR and Zhang W:
Circulating plasma MiR-141 is a novel biomarker for metastatic
colon cancer and predicts poor prognosis. PLoS One. 6:e177452011.
View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Subramanian S, Lui WO, Lee CH, Espinosa I,
Nielsen TO, Heinrich MC, Corless CL, Fire AZ and van de Rijn M:
MicroRNA expression signature of human sarcomas. Oncogene.
27:2015–2026. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Osaki M, Takeshita F and Ochiya T:
MicroRNAs as biomarkers and therapeutic drugs in human cancer.
Biomarkers. 13:658–670. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Nair VS, Maeda LS and Ioannidis JP:
Clinical outcome prediction by microRNAs in human cancer: A
systematic review. J Natl Cancer Inst. 104:528–540. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu
Y, Chen Y, Xu L, Zen K, Zhang C and Shen H: Serum microRNA
signatures identified in a genome-wide serum microRNA expression
profiling predict survival of non-small-cell lung cancer. J Clin
Oncol. 28:1721–1726. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Zuo Z, Calin GA, de Paula HM, Medeiros LJ,
Fernandez MH, Shimizu M, Garcia-Manero G and Bueso-Ramos CE:
Circulating microRNAs let-7a and miR-16 predict progression-free
survival and overall survival in patients with myelodysplastic
syndrome. Blood. 118:413–415. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Zhang MX, Li J, Shen GP, Zou X, Xu JJ,
Jiang R, You R, Hua YJ, Sun Y, Ma J, et al: Intensity-modulated
radiotherapy prolongs the survival of patients with nasopharyngeal
carcinoma compared with conventional two-dimensional radiotherapy:
A 10-year experience with a large cohort and long follow-up. Eur J
Cancer. 51:2587–2595. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Chung IC, Chen LC, Chung AK, Chao M, Huang
HY, Hsueh C, Tsang NM, Chang KP, Liang Y, Li HP and Chang YS:
Matrix metalloproteinase 12 is induced by heterogeneous nuclear
ribonucleoprotein K and promotes migration and invasion in
nasopharyngeal carcinoma. BMC Cancer. 14:3482014. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Yi W, Li X, Liu Z, Jiang C, Niu D and Xia
Y: A risk score model for the metastasis of level Ib lymph node
based on the clinicopathological features of nasopharyngeal
carcinoma in a large sample. Mol Clin Oncol. 2:789–797. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Shi Q, Shen C, Kong L, Wang X, Ding J, Gao
Y, Xu T and Hu C: Involvement of both cervical lymph nodes and
retropharyngeal lymph nodes has prognostic value for N1 patients
with nasopharyngeal carcinoma. Radiat Oncol. 9:72014. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Wang HZ, Cao CN, Luo JW, Yi JL, Huang XD,
Zhang SP, Wang K, Qu Y, Xiao JP, Li SY, et al: High-risk factors of
parotid lymph node metastasis in nasopharyngeal carcinoma: A
case-control study. Radiat Oncol. 11:1132016. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Tang LL, Tang XR, Li WF, Chen L, Tian L,
Lin AH, Sun Y and Ma J: The feasibility of contralateral lower neck
sparing intensity modulation radiated therapy for nasopharyngeal
carcinoma patients with unilateral cervical lymph node involvement.
Oral Oncol. 69:68–73. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Zhang Y, Li WF, Chen L, Mao YP, Guo R,
Zhang F, Peng H, Liu LZ, Li L, Liu Q and Ma J: Prognostic value of
parotid lymph node metastasis in patients with nasopharyngeal
carcinoma receiving intensity-modulated radiotherapy. Sci Rep.
5:139192015. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Tagawa T, Albanese M, Bouvet M, Moosman A,
Mautner J, Heissmeyer V Zielinski C, Hoser J, Hastreiter M, Hayes
M, et al: Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell
responses targeting IL-12 and peptide processing. J Exp Med.
213:2065–2080. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Feederle R, Haar J, Bernhardt K,
Linnstaedt SD, Bannert H, Lips H, Cullen BR and Delecluse HJ: The
members of an Epstein-Barr virus microRNA cluster cooperate to
transform B lymphocytes. J Virol. 85:9801–9810. 2011. View Article : Google Scholar : PubMed/NCBI
|
